Go Pro

Colgate-Palmolive (NYSE:CL) Stock Sold Off by Rep. Kevin Hern

Colgate-Palmolive logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Rep. Kevin Hern sold between $1,001 and $15,000 of Colgate-Palmolive stock from his traditional IRA on August 31, according to a disclosure filed September 25. He also reported selling shares of several other companies in September.
  • Colgate-Palmolive opened at $86.51, while analysts maintained a generally favorable outlook, with a “Moderate Buy” consensus and an average price target of $98.94.
  • The company beat quarterly earnings expectations, reporting $0.99 in EPS and $5.36 billion in revenue, while declaring a quarterly dividend of $0.53, equivalent to a 2.5% annualized yield.
  • Five stocks we like better than Colgate-Palmolive.

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Colgate-Palmolive Company NYSE: CL. In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on August 31st. The trade occurred in the Representative's "KEVIN HERN TRADITIONAL IRA" account.

Representative Kevin Hern also recently made the following trade(s):

  • Sold $15,001 - $50,000 in shares of CenterPoint Energy NYSE: CNP on 9/15/2026.
  • Sold $1,001 - $15,000 in shares of TJX Companies NYSE: TJX on 9/15/2026.
  • Sold $15,001 - $50,000 in shares of STERIS NYSE: STE on 9/15/2026.
  • Sold $1,001 - $15,000 in shares of Seagate Technology NASDAQ: STX on 9/15/2026.
  • Sold $15,001 - $50,000 in shares of NextEra Energy NYSE: NEE on 9/14/2026.
  • Sold $1,001 - $15,000 in shares of Marsh & McLennan Companies NYSE: MRSH on 9/14/2026.
  • Sold $15,001 - $50,000 in shares of IQVIA NYSE: IQV on 9/14/2026.
  • Sold $15,001 - $50,000 in shares of Home Depot NYSE: HD on 9/14/2026.
  • Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 9/14/2026.
  • Sold $15,001 - $50,000 in shares of Emerson Electric NYSE: EMR on 9/14/2026.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $86.51 on Tuesday. The stock has a market cap of $68.96 billion, a P/E ratio of 34.33, a PEG ratio of 4.01 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The business's 50-day moving average price is $90.04 and its two-hundred day moving average price is $88.88. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, beating analysts' consensus estimates of $0.95 by $0.04. The business had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. Colgate-Palmolive's quarterly revenue was up 4.9% on a year-over-year basis. During the same period last year, the firm posted $0.92 earnings per share. As a group, equities analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 84.13%.

Insider Activity

In related news, Director John T. Cahill sold 4,170 shares of the company's stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of the firm's stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the sale, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This trade represents a 13.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 175,191 shares of company stock valued at $16,110,903. 0.43% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

CL has been the subject of a number of research analyst reports. UBS Group lifted their price objective on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the stock a "buy" rating in a report on Monday, August 3rd. Royal Bank Of Canada restated an "outperform" rating and set a $104.00 price target on shares of Colgate-Palmolive in a research report on Tuesday, September 8th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Wells Fargo & Company increased their price objective on Colgate-Palmolive from $92.00 to $95.00 and gave the company an "equal weight" rating in a research report on Wednesday, July 8th. Finally, Piper Sandler decreased their price objective on Colgate-Palmolive from $98.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, September 21st. Thirteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of "Moderate Buy" and a consensus target price of $98.94.

Read Our Latest Stock Analysis on Colgate-Palmolive

Institutional Trading of Colgate-Palmolive

Several institutional investors have recently added to or reduced their stakes in the business. QRG Capital Management Inc. lifted its stake in shares of Colgate-Palmolive by 466.3% in the 2nd quarter. QRG Capital Management Inc. now owns 215,380 shares of the company's stock valued at $19,746,000 after acquiring an additional 177,350 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its position in Colgate-Palmolive by 257.3% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 69,161 shares of the company's stock worth $6,341,000 after acquiring an additional 49,803 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in Colgate-Palmolive by 266.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 4,146,337 shares of the company's stock worth $380,136,000 after purchasing an additional 3,014,860 shares during the period. Andra AP fonden purchased a new position in Colgate-Palmolive in the 2nd quarter worth approximately $18,214,000. Finally, State Street Corp lifted its position in Colgate-Palmolive by 97.4% in the second quarter. State Street Corp now owns 94,195,992 shares of the company's stock valued at $8,635,889,000 after purchasing an additional 46,476,510 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma's 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027. Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma's 1st Congressional District. He declared candidacy for the 2026 election. Kevin Hern went into business as a McDonald's franchisee in 1999. He acquired 10 McDonald's franchises by 2012. He served on the McDonald's National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom's of Maine and Hill's Science Diet.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines